SLC25A26
Basic information
Region (hg38): 3:66133610-66388116
Links
Phenotypes
GenCC
Source:
- combined oxidative phosphorylation deficiency 28 (Strong), mode of inheritance: AR
- combined oxidative phosphorylation deficiency 28 (Supportive), mode of inheritance: AR
- combined oxidative phosphorylation deficiency 28 (Strong), mode of inheritance: AR
- mitochondrial disease (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Combined oxidative phosphorylation deficiency 28 | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Biochemical; Cardiovascular; Neurologic | 26522469 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (76 variants)
- Inborn_genetic_diseases (51 variants)
- Combined_oxidative_phosphorylation_deficiency_28 (11 variants)
- SLC25A26-related_disorder (4 variants)
- not_specified (1 variants)
- Hypokalemic_periodic_paralysis,_type_1 (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SLC25A26 gene is commonly pathogenic or not. These statistics are base on transcript: NM_001379210.1. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 16 | 18 | ||||
missense | 54 | 65 | ||||
nonsense | 2 | |||||
start loss | 0 | |||||
frameshift | 2 | |||||
splice donor/acceptor (+/-2bp) | 2 | |||||
Total | 5 | 2 | 59 | 22 | 1 |
Highest pathogenic variant AF is 0.0000295722
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SLC25A26 | protein_coding | protein_coding | ENST00000354883 | 10 | 319256 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.58e-7 | 0.507 | 125553 | 0 | 40 | 125593 | 0.000159 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.391 | 144 | 131 | 1.10 | 0.00000635 | 1711 |
Missense in Polyphen | 41 | 39.812 | 1.0298 | 499 | ||
Synonymous | 0.511 | 45 | 49.6 | 0.908 | 0.00000243 | 558 |
Loss of Function | 0.870 | 12 | 15.7 | 0.763 | 7.96e-7 | 199 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000390 | 0.000386 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000222 | 0.000218 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000192 | 0.000176 |
Middle Eastern | 0.000222 | 0.000218 |
South Asian | 0.000100 | 0.0000980 |
Other | 0.000327 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Mitochondrial solute carriers shuttle metabolites, nucleotides, and cofactors through the mitochondrial inner membrane. Specifically mediates the transport of S- adenosylmethionine (SAM) into the mitochondria. {ECO:0000269|PubMed:14674884, ECO:0000269|PubMed:26522469}.;
- Pathway
- Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Transport of small molecules;Methionine and cysteine metabolism
(Consensus)
Recessive Scores
- pRec
- 0.0908
Intolerance Scores
- loftool
- 0.693
- rvis_EVS
- -0.07
- rvis_percentile_EVS
- 48.12
Haploinsufficiency Scores
- pHI
- 0.100
- hipred
- N
- hipred_score
- 0.255
- ghis
- 0.508
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0167
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Slc25a26
- Phenotype
- growth/size/body region phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); embryo phenotype;
Gene ontology
- Biological process
- ion transport;S-adenosyl-L-methionine transport;S-adenosyl-L-methionine transmembrane transport
- Cellular component
- mitochondrion;mitochondrial inner membrane;integral component of membrane
- Molecular function
- S-adenosyl-L-methionine transmembrane transporter activity